GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fosun Pharmaceutical (Group) Co Ltd (OTCPK:SFOSF) » Definitions » Long-Term Debt

SFOSF (Shanghai Fosun Pharmaceutical (Group) Co) Long-Term Debt : $1,434 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Shanghai Fosun Pharmaceutical (Group) Co Long-Term Debt?

Shanghai Fosun Pharmaceutical (Group) Co's Long-Term Debt for the quarter that ended in Dec. 2024 was $1,434 Mil.

Shanghai Fosun Pharmaceutical (Group) Co's quarterly Long-Term Debt declined from Jun. 2024 ($1,351 Mil) to Sep. 2024 ($1,254 Mil) but then increased from Sep. 2024 ($1,254 Mil) to Dec. 2024 ($1,434 Mil).

Shanghai Fosun Pharmaceutical (Group) Co's annual Long-Term Debt increased from Dec. 2022 ($1,736 Mil) to Dec. 2023 ($1,891 Mil) but then declined from Dec. 2023 ($1,891 Mil) to Dec. 2024 ($1,434 Mil).


Shanghai Fosun Pharmaceutical (Group) Co Long-Term Debt Historical Data

The historical data trend for Shanghai Fosun Pharmaceutical (Group) Co's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fosun Pharmaceutical (Group) Co Long-Term Debt Chart

Shanghai Fosun Pharmaceutical (Group) Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,296.12 1,420.73 1,735.57 1,891.39 1,434.41

Shanghai Fosun Pharmaceutical (Group) Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,891.39 1,830.86 1,350.75 1,253.56 1,434.41

Shanghai Fosun Pharmaceutical (Group) Co  (OTCPK:SFOSF) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.


Shanghai Fosun Pharmaceutical (Group) Co Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Shanghai Fosun Pharmaceutical (Group) Co's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Fosun Pharmaceutical (Group) Co Business Description

Address
No. 1289 Yishan Road, Building A, Fosun Technology Park, Shanghai, CHN, 200233
Shanghai Fosun Pharmaceutical (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceutical products and medical equipment, the import and export of medical equipment, and the provision of related and other consulting services and investment management. Its business segments are Pharmaceutical manufacturing, Healthcare Services, Medical devices, and medical diagnosis. It generates the majority of its revenue from the Pharmaceutical manufacturing segment. The company considers merger and acquisition investment as a potential component of its operational growth for expanding its research, development, manufacturing, and marketing capabilities. Its geographic areas are the Chinese mainland, Regions outside the Chinese mainland, and other countries.